Committee Composition

Board of Directors Audit Committee Compensation Committee Nominating and Governance Committee
Todd C. Brady, M.D., Ph.D. Board of Directors
Ben R. Bronstein, M.D Board of Directors Audit Committee Nominating and Governance Committee
Richard H. Douglas, Ph.D. Board of Directors Nominating and Governance Committee
Martin J. Joyce Board of Directors Audit Committee Nominating and Governance Committee
Nancy Miller-Rich Board of Directors Compensation Committee
Gary Phillips, M.D. Board of Directors Audit Committee Compensation Committee
Neal S. Walker, D.O. Board of Directors Compensation Committee
= Chairperson = Member = Chairman of the Board

Safe Harbor Disclosure

This video content contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding Aldeyra’s possible or assumed future results of operations, expenses and financing needs, business strategies and plans, research and development plans or expectations, trends, the structure, timing and success of Aldeyra’s planned or pending clinical trials, expected milestones, market sizing, pricing and reimbursement, competitive position, regulatory matters, industry environment and potential growth opportunities, among other things. Actual results or trends could differ materially from those contemplated by these forward-looking statements. For more information, please refer to the risk factors discussed in Aldeyra's periodic filings with the SEC, including the most recent Form 10-Q or 10-K. Any forward-looking statements that are made in the video content are based on assumptions as of the original date of the creation of such video, and Aldeyra undertakes no obligation to update these statements as a result of new information or future events.

Continue to video